Web Page

This overview of opioids from the NSC includes information on opioid misuse, recognizing signs of an overdose, prescription painkillers and chronic pain, and more.

SUDORS provides comprehensive data on unintentional and undetermined intent drug overdose deaths collected from death certificates and medical examiner/coroner reports.

This page offers background information and tips for providers to keep in mind while using person-first language, as well as terms to avoid to reduce stigma and negative bias when discussing addiction.

This SAMHSA page includes information on 2023 training requirements that eliminated the DATA waiver that was previously needed to prescribe buprenorphine and expanded the number of DEA-registered practitioners able to treat people with opioid use disorder.

This SAMHSA page provides guiding principles and resources on recovery and recovery support for people with substance use disorder.

This page from SAMHSA's Office of Behavioral Health Equity includes information on the drivers of behavioral health inequities and resources for several underrepresented populations.

To help key stakeholders understand and differentiate digital therapeutics from the thousands of other mobile health apps that are available, this library highlights evidence-based innovative digital therapeutics products.

This website provides information, videos, training, and other resource information for implementing technology assisted treatments/care to improve the quality and reach of treatment services for persons with substance use disorders.

This website provides evaluations for mental health apps, including those related to substance use, based on app credibility, user experience, and transparency of privacy practices.

This page provides an overview on Digital therapeutics, which deliver patients evidence-based therapeutic interventions that are driven by high quality software programs to treat, manage, or prevent a disease or disorder.